PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Oct 29, 2020, after the close
10-Q filed Oct 29, 2020, 29 days after period end · 0001070081-20-000139
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $118.40M | $71.42M | $53.59M | $41.78M |
| Net Income | -$69.69M | -$60.00M | -$50.97M | -$33.74M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$1.03 |
| -$1.06 |
| -$1.06 |
| -$0.82 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.